Skip to content

Turkey tail mushroom (wrośniak różnobarwny): a complete guide

Turkey tail (wrośniak różnobarwny, Trametes versicolor): what it is, how it looks, where it grows, TCM tradition and what studies show, with limits.

Mateusz Rosa

TCM therapist · Doctor of Acupuncture (WFAS) · author of a book on functional mushrooms

7 min read

Turkey tail mushroom (wrośniak różnobarwny): a complete guide
Contents

Turkey tail (Trametes versicolor) is a bracket mushroom with fan-shaped, banded fruiting bodies. In Polish it is called wrośniak różnobarwny, and in shops it is often sold as coriolus. It grows commonly in Polish deciduous forests, and in supplements it is used as an extract.

This guide covers the names, the look, TCM tradition, the research with its limits, and safety. Narrower topics such as dosage and product forms have their own posts, linked in the text.

What is turkey tail, and how does it relate to coriolus?

Turkey tail is the English name of the mushroom Trametes versicolor, a member of the Polyporaceae family. Coriolus is its trade name and an older Latin synonym (Coriolus versicolor), and wrośniak różnobarwny is the Polish name. All four terms describe one species, so compare Latin names on labels, not the language of the packaging.

The confusion comes from taxonomic history: the species was classified in the genera Polyporus and Coriolus, and today the accepted name is Trametes versicolor. In Chinese tradition it is yun zhi, the "cloud mushroom", and in Japanese kawaratake, the "roof-tile mushroom".

What does turkey tail look like and where does it grow in Poland?

Turkey tail forms thin, fan-shaped fruiting bodies layered like roof tiles on the trunks of deciduous trees, with concentric bands of brown, grey, cream and blue-grey. In Poland it grows commonly in deciduous and mixed forests, most often on dead or dying birch, beech and oak wood, through most of the year.

The banded pattern, resembling a spread bird's tail from a distance, gave the species its English name. The underside is pale and porous, without gills. Wild specimens are not suitable for supplements, because they can accumulate metals and their content of active compounds is unpredictable. Raw material for an extract comes from controlled cultivation on a substrate of beech sawdust and bran.

Fruiting body or grain-grown mycelium: how do you read a turkey tail extract label?

A turkey tail extract is made either from the fruiting body, the mature visible part of the mushroom, or from mycelium grown on grain and dried together with the substrate. These are two different raw materials. On the label check the mushroom part, the standardization ratio such as 10:1, the product form and the daily serving.

Mycelium grown on grain contains a lot of starch from the substrate, and cheap products can count it among the declared polysaccharides. Our extract comes from the fruiting body, at a 10:1 ratio, standardized to at least 30% beta-glucans, with no maltodextrin. A full label-reading walkthrough is in coriolus extract: 10:1, PSK and PSP, and the raw-material difference is covered in fruiting body or grain-grown mycelium.

What does TCM tradition say about turkey tail?

In Chinese tradition turkey tail is yun zhi, the cloud mushroom, described in the compendium Ben Cao Gang Mu in 1578. Tradition classed it among tonics of Spleen and Lung Qi, with a sweet taste and a slightly cool nature. This is a cultural story, not a promise or a health recommendation.

Li Shizhen placed it in the "shang yao" category, the highest class of tonics, described as gentle with long use. In tradition it is not taken continuously but in cycles of several weeks, most often in autumn and winter. Concepts such as Qi or meridian do not map directly onto Western anatomy. More on symbolism and forms is in coriolus: TCM tradition, forms and choosing an extract.

What do studies say about turkey tail, and what are their limits?

Research on turkey tail concerns mainly the polysaccharide fractions PSK and PSP, described in laboratory and animal work. Human studies are few and small. The best described is an 8-week randomized trial in 24 healthy volunteers that assessed the effect of PSP on gut microbiota (PMID 25006989).

In that study (Pallav and colleagues, 2014, PMID 25006989, doi 10.4161/gmic.29558) volunteers took 3600 mg of PSP a day for 8 weeks, and the authors described changes in microbiota composition, including a rise in Bifidobacterium and Lactobacillus. The result concerns bacteria counts, not health status.

The limits are worth stating plainly:

  • most data on immunity come from in vitro and animal studies (review: Saleh and colleagues, 2017, PMID 28932226),
  • the human trial was small, and results need replication in larger studies,
  • PSK and PSP are isolated fractions, while a fruiting-body supplement is a different product with a different concentration and regulatory path,
  • "boosts immunity" has no hard measure, because immunity is not a single parameter.

Studies describe mechanisms and tendencies. They are not a promise of an effect in any one person.

How is turkey tail extract used?

Turkey tail extract is used according to the label of the specific product: a daily serving taken with water, ideally at a steady time, in the morning or before noon. It is sold as capsules, powder and drops. Never exceed the recommended serving, and treat doses from studies as information, not as a recommendation.

Tradition and our own materials describe seasonal use, in cycles of several weeks with breaks, rather than all year without a pause. Serving size, time of day and how to assess a ritual are in the post on coriolus dosage, and choosing a form is in capsules, powder or drops. You can check current forms and price on the turkey tail extract product page.

When should you talk to a doctor before using turkey tail?

Turkey tail is not used after a transplant with immunosuppression, during a flare of autoimmune disease, in children or with a mushroom allergy. Anticoagulant medication, oncology treatment, pregnancy, breastfeeding and planned surgery call for a doctor's advice first. It is a food supplement, not a medicine, and does not replace medical advice.

Autoimmune disease in remission should also be discussed with your doctor before the first serving. Before planned surgery our materials advise stopping the extract at least 14 days earlier. Reported complaints are mainly mild, temporary digestive symptoms in the first week. If itching, swelling or shortness of breath appears, stop the product and contact a doctor.

FAQ

Turkey tail capsules: how do they differ from powder and drops? It is the same raw material in three forms, so the difference is convenience and taste, not species. Capsules are neutral in taste, powder goes into a drink, drops are measured with a dropper. A comparison is in capsules, powder or drops.

Turkey tail dosage: how much per day? According to the label of the product you choose. A study in healthy volunteers used 3600 mg of PSP a day for 8 weeks (PMID 25006989), but that is a research dose, not a recommendation. Details are in the post on coriolus dosage.

Turkey tail reviews: where can you read them? Customer reviews of our extract are on the product page. A review describes one person's experience, so it is not proof of an effect and does not replace studies or a conversation with your doctor.

Turkey tail contraindications: who should be careful? It is not used after a transplant with immunosuppression, during an autoimmune flare, in children or with a mushroom allergy. With anticoagulants, oncology treatment, pregnancy, breastfeeding or planned surgery, talk to your doctor first.

Turkey tail mycelium: is it the same as a fruiting-body extract? No. Mycelium grown on grain is a different raw material from the fruiting body, with a different composition and a lot of starch from the substrate. The label should state which part of the mushroom the extract comes from.

Turkey tail has several posts on this blog, each expanding one thread: TCM tradition and forms, dosage according to the label, reading an extract label, and choosing between capsules, powder and drops. The articles below add what this guide deliberately does not repeat.

Author: Mateusz Rosa, TCM practitioner and founder of Aloha Fungi · about us


This content is for educational purposes only and does not constitute medical advice. A food supplement does not replace a varied diet or a healthy lifestyle. If in doubt, consult your doctor or pharmacist.

Turkey tail (Coriolus) in scientific research

What was studied, on how many people and with what level of evidence. This overview describes studies, not the effects of a product.

10

human studies

2

placebo-controlled RCTs

2003–2026

years of publication

  • Pilkington K. et al., 2022

    A

    Cochrane review with meta-analysis (PSK, drug)

    7 RCTs, 1569 people

    The Cochrane systematic review with meta-analysis collected 7 RCTs (1569 people) on the effect of PSK (a pharmaceutical drug, not a supplement) on adverse effects of chemotherapy/radiotherapy in colorectal cancer.

    PMID 36445793
  • Oba K. et al., 2006

    A

    meta-analysis of RCTs (PSK, drug)

    8 RCTs, 8009 patients

    The meta-analysis of RCTs collected 8 studies (8009 patients) on PSK (a drug) as adjunct therapy in gastric cancer.

    PMID 17106715
  • Ma Y. et al., 2017

    B

    network meta-analysis (PSK, drug)

    23 studies, 10,684 patients

    The network meta-analysis collected 23 studies (10,684 patients) on PSK (a drug) in gastrointestinal cancers.

    PMID 29179503
  • Zhong L. et al., 2019

    B

    meta-analysis of RCTs

    23 studies, 4246 people

    The meta-analysis of RCTs collected 23 studies (4246 people) on Coriolus versicolor and Ganoderma lucidum preparations used as adjunct therapy in oncology patients.

    PMID 31333449
  • Tsang K.W. et al., 2003

    C

    pilot RCT, placebo-controlled (PSP, drug)

    68 people

    The pilot placebo-controlled RCT examined PSP (a drug) in non-small cell lung cancer (NSCLC) in 68 people.

    PMID 12814145
  • Torkelson C.J. et al., 2012

    D

    phase I, dose escalation (whole extract, not a drug)

    11 recruited, 9 completed

    The phase I dose-escalation study examined the safety and tolerability of a whole Trametes versicolor extract (not the purified PSK/PSP drug) in women after radiotherapy for breast cancer. 11 recruited, 9 completed.

    PMID 22701186
  • Pallav K. et al., 2014

    C

    RCT (PSP, drug)

    24 recruited, 22 completed

    The RCT examined the effect of PSP (a drug) combined with amoxicillin on the gut microbiome of healthy people. 24 recruited, 22 completed.

    PMID 25006989
  • Koda K. et al., 2003

    C

    RCT (PSK, drug)

    558 people

    The RCT examined PSK (a drug) added to postoperative chemotherapy in 558 people.

    PMID 12792790
  • Yu Z.T. et al., 2013

    E

    in vitro (human faecal fermentation, PSP) · preclinical studies (in vitro and rodent)

    number of donors not specified

    The in vitro study examined the fermentation of PSP by human faecal microbiota cultured outside the body (bacterial composition, pH) compared with fructooligosaccharides.

    PMID 23435630
  • Saleh M.H. et al., 2017

    E

    narrative review (PSP) · preclinical studies (in vitro and rodent)

    not applicable

    The narrative review discussed the immunomodulatory mechanisms of PSP (cytokines, tumour microenvironment) in the context of adjuvant therapy in Asia.

    PMID 28932226
  • Wenner C.A. et al., 2012

    E

    animal (mice, PSK) · preclinical studies (in vitro and rodent)

    not specified

    The mouse study examined PSK (a drug) combined with docetaxel (tumour size, lymphocyte infiltration, NK cell activity).

    PMID 22159900
  • Standish L.J. et al., 2008

    E

    narrative review (PSK) · preclinical studies (in vitro and rodent)

    not applicable

    The review synthesised Asian RCTs on PSK (a drug: gastric, colorectal, oesophageal, breast cancer) and immunological mechanisms. No data on the effect of the whole extract as distinct from PSK.

    PMID 19087769
  • Wong E.L.Y. et al., 2012

    B

    systematic review with meta-analysis (PSK, drug)

    13 clinical studies

    The meta-analysis examined the effect of PSK (a drug) preparations added to standard treatment on survival of cancer patients, based on 13 clinical studies.

    PMID 22185453
  • Habtemariam S., 2020

    E

    narrative review (PSP and PSK) · preclinical studies (in vitro and rodent)

    not applicable

    The review synthesised in vitro, in vivo and clinical evidence for commercial PSP and PSK preparations as adjunct therapy.

    PMID 32466253
  • Cui J., Chisti Y., 2003

    E

    narrative review, bioprocess-focused (PSP) · preclinical studies (in vitro and rodent)

    not applicable

    The narrative review focused on the biotechnological production of PSP, with a brief discussion of biological activity.

    PMID 14499133
  • Knežević A. et al., 2018

    E

    in vitro, 3 Trametes species · preclinical studies (in vitro and rodent)

    not applicable

    The in vitro study examined antioxidant, antifungal, cytotoxic activity and acetylcholinesterase/tyrosinase inhibition for extracts of three Trametes species from Serbia.

    PMID 30169542
  • Muszyńska B. et al., 2018

    E

    general review (not specifically about Coriolus) · preclinical studies (in vitro and rodent)

    not applicable

    General review of the anti-inflammatory properties of edible mushrooms; does not specifically concern Coriolus, a source shared across multiple species hubs.

    PMID 29146352
  • Saxe G. et al., 2026

    C

    RCT, double-blind, placebo-controlled (combined FoTv preparation, not Coriolus alone)

    90 (52 FoTv, 38 placebo)

    The RCT examined the safety and feasibility of administering the FoTv mycelium preparation (Fomitopsis officinalis + Trametes versicolor) as an adjunct to COVID-19 vaccination, with observation up to 6 months. A combined preparation of two species; results cannot be attributed to Trametes versicolor alone.

    PMID 41620671
  • Ziaja-Sołtys M., Jaszek M., 2025

    E

    review (no full PRISMA protocol), mostly preclinical · preclinical studies (in vitro and rodent)

    11 studies, including 1 phase I study (= 5.6)

    The review collected 11 studies (2010-2025) on Coriolus versicolor in breast cancer, mostly cell lines and mice, plus one phase I study. Larger placebo-controlled studies are needed.

    DOI 10.3390/cimb47100808

Evidence levels: A · Cochrane review · B · systematic review · C · placebo RCT · D · pilot RCT · E · preclinical studies

What these studies don't say

  • Samples are usually small, most from a single population.
  • Results describe research interventions, not a dietary supplement.
  • The presence of a study is not a health claim.

Source: Aloha Fungi literature review, 1 September 2026; entries verified via PubMed or by DOI (Crossref). See the research

Discover functional mushrooms

© 2026 Aloha Fungi™